GOLDSMITH MARK A bought RVMD
March 1, 2026 · Form 4 insider transaction
GOLDSMITH MARK A bought 57,100 shares of Revolution Medicines, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
57,100
Price
$0.00
Total value
N/A
InsiderGOLDSMITH MARK A
RoleOfficer, Director
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateMarch 1, 2026
Filing dateMarch 3, 2026
Shares owned after289,569
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Includes 225,863 restricted stock units.; Reflects the transfer of 24,010 shares to the Mark A. Goldsmith and Anne E. Midler 2002 Revocable Living Trust.